IEIL to Acquire Arysta LifeScience Corporation From Olympus Capital Holdings Asia

Industrial Equity Investments Limited ("IEIL"), an international
investment company located in the Republic of Ireland, today announced
it has signed a definitive agreement to acquire Arysta LifeScience
Corporation, from funds advised by Olympus Capital Holdings Asia and
its co-investors. The acquisition is IEIL's first investment in Japan
since it was established in 2005. The Permira Funds own the Irish
company. The enterprise value is approximately JPY 250bn (US$2.2bn).
Completion of the transaction, which is subject to regulatory review
and approvals, is anticipated to occur in first quarter 2008.

Headquartered in Tokyo, Arysta LifeScience is the world's tenth
largest agrochemical company. The company markets a portfolio of over
150 products in more than 125 countries with approximately 2,200
employees. Since its founding in 2001, Arysta LifeScience has built a
reputation as one of the most agile, high-performance companies in the
global agrochemical industry.

Margaret O'Connor, chairperson of IEIL, commented, "We are
delighted to be acquiring a truly global business headquartered in
Japan and look forward to supporting the management in their growth
going forward."

Chris Richards, CEO of Arysta LifeScience, said, "Our continued
success comes from a culture that is relentlessly focused on
delivering innovative crop protection solutions that help our
customers become more successful. Based on our strong product range
and global reach, our employees have driven aggressive global growth
through product development and strategic acquisition. Olympus Capital
has provided consistent support for our growth over the last five
years. We are now excited to look to the future with IEIL, who shares
our vision and ambition to further accelerate our growth plans over
the coming years."

Olympus Capital, an independent firm that has been in the Asian
private equity business for more than 10 years, has entered into more
than 10 strategic partnerships throughout the region. The firm
completed an initial investment in Arysta LifeScience in 2002,
partnering with then existing owners Tomen Corporation (now owned by
Toyota Tsusho) and Nichimen Corporation (now part of Sojitz
Corporation), who subsequently sold their stakes to the Olympus Group.
During this period, Olympus Capital helped Arysta LifeScience to
acquire more than JPY50bn (US$450 million) of companies and products
around the world.

The Permira Funds provided all the equity for the IEIL's first
acquisition in Japan. This investment demonstrates Permira's ability
to identify strong investment opportunities in the region following
its recent investment in Galaxy Entertainment Group of Hong Kong.

Goldman Sachs, Lehman Brothers and Freshfields Bruckhaus Deringer
acted as advisers to Arysta LifeScience and the sellers. JP Morgan,
Clifford Chance, PricewaterhouseCoopers and Permira Ireland Limited
acted as advisers to IEIL.

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's
largest privately held crop protection and life science company with
2006 revenues of JPY124.1 billion (US$1 billion). An entrepreneurial
provider of crop protection and life science products in more than 125
countries worldwide, Arysta LifeScience specializes in marketing and
distribution of respected crop protection brands and life science
products in harmony with the needs of global partners. More
information on the company is available at: www.arystalifescience.com.

About IEIL

Established in 2005, IEIL is a private investment company located
in the Republic of Ireland.

About Permira

Permira is a leading international private equity firm. The
Permira Funds make long-term investments to transform the performance
of businesses, helping management to realise new visions and build
stronger and more sustainable organizations.

The firm's teams are based in Frankfurt, Guernsey, London,
Luxembourg, Madrid, Milan, New York, Paris, Stockholm, and Tokyo,
advising funds with a total committed capital of approximately EUR22
billion (US$30 billion). Since 1985, the Permira Funds have completed
over 180 private equity transactions.

For more information visit: www.permira.com

About Olympus Capital Holdings Asia

Olympus Capital Holdings Asia is a leading middle market private
equity firm specializing in partnering with Asian shareholders and
management teams to expand their businesses regionally and globally.
Olympus Capital has a network of investment and operating
professionals located in offices in Tokyo, Delhi, Hong Kong, Seoul,
Shanghai and New York. Since its establishment in 1997, Olympus
Capital has invested over $1.2 billion on behalf of funds and
co-investors in more than 25 portfolio companies throughout Asia.
Olympus Capital, one of the early entrants to the Japan private equity
market, completed its first Japanese investments in partnership with a
major Japanese bank and a trading company in 2000, and established its
Tokyo office soon thereafter in 2001. Target industry sectors include
business services, agribusiness, financial services and environmental
services. Recent investments include Quatrro BPO Solutions (India) and
Kyoto Kimono Yuzen (Japan).